Table 2.
Clinical data and preoperative characteristics of the three groups of patients.
| Gleason ≤ 6 | Gleason = 7 | Gleason ≤ 7 | |
|---|---|---|---|
| AGE | |||
| (mean ± SD/range; median) | 63.2 ± 6.5 (43–74); 62 | 65.4 ± 6.4 (41–77); 67 | 64.3 ± 6.4 (41–77); 64 |
| PSA | |||
| (mean ± SD/range; median) | 6.5 ± 7.2 (2.2–18.7); 5,8 | 7.7 ± 3.95 (0.13–19.66); 8,2 | 7.83 ± 3.74 (0.13–19.66); 9,8 |
| CLINICAL STAGE | |||
| cT1a-cT1c | 956 (89.8%) | 159 (38.3%) | 1115 (75.4%) |
| cT2 | 107 (10.2%) | 256 (61.7%) | 363 (24,6%) |
| SURGERY | |||
| RRP | 865 (81.4%) | 324 (77.97%) | 1189 (80.4%) |
| ROB | 136 (12.8%) | 61 (14.77%) | 197 (13.3%) |
| LAP | 62 (5.8%) | 30 (7.3%) | 93 (6.3%) |